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Background: There is little understanding of the reasons for the limited communication between patients and
conventional healthcare professionals regarding patients’ use of complementary and alternative medicine (CAM).
The purpose of this study is to explore the predictors of outpatients’ decision to disclose their use of natural
products to conventional healthcare professionals.
Methods: A mixed method design was used. Quantitative data were obtained through a survey and qualitative
data were obtained from semi-structured interviews. A total of 257 outpatients who fulfilled the criteria of having
used natural products prior to the interview were recruited for this study. Subsequently, 39 patients of those who
completed the survey were further selected to take part in an in-depth qualitative interview.
Results: Predictors of the decision to disclose the use of natural products to conventional healthcare professionals
included age, frequency of clinic visits, knowledge of the natural products and the attitude towards the benefits of
CAM use. The themes that emerged from the qualitative data included safeness of the natural products, consulting
alternative sources of information, apprehension regarding the development of negative relationships with
healthcare professionals and reactions from the healthcare professionals.
Conclusions: Understanding the factors and reasons affecting patients’ decision as to whether to disclose their use
of natural products provides an opportunity for conventional healthcare professionals to communicate better with
patients. It is important to encourage patients to disclose their use of natural products in order to provide
responsible health care as well as increasing patient safety regarding medication usage.
Keywords: Natural products, Disclosure, Communication, Decision, Mixed methods researchBackground
Complementary and alternative medicine (CAM) refers
to a set of healthcare beliefs, approaches, and products
that are infrequently taught to conventional healthcare
students, and are not generally available at hospitals
[1,2]. When compared to Western countries such as the
USA (38.3%) [3] and Australia (52.2%) [4], rates of CAM
use are exceptionally high among individuals from coun-
tries with long histories such as Singapore (76%) [5],
Japan (76%) [6], Turkey (70%) [7] and Taiwan (75.5%)
[8]. Most users of CAM treatment are often resistant to-
wards abandoning CAM in favour of conventional* Correspondence: chang369@gmail.com
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stated.treatments, but rather preferring a range of available op-
tions that complement conventional medicine [9]. As
such, many CAM users do not divulge information
about their CAM use to conventional healthcare profes-
sionals. Recent studies showed the overall rate of non-
disclosure of CAM use remains high, between 48.2%
and 73.4% [9-11]. In addition, the decision on whether
to disclose CAM use to conventional healthcare profes-
sionals also varies among patient populations. In the US,
studies found that only 39.8% of CAM users disclosed
their use with physicians in 1990 and, in 1997, an even
lower 38.5% disclosed this information [12,13]. The
highest rate of non-disclosure in CAM use was found in
patients with end-stage renal disease (ESRD) receiving
haemodialysis in Taiwan, where 98% of the CAM usersLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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physicians [14]. Although previous studies have exten-
sively explored the rates of disclosure or non-disclosure
of CAM use to conventional healthcare professionals,
there is little understanding of the reasons for this lim-
ited communication and the factors influencing this gap
in communication.
The use of natural products within CAM has been
shown to be a popular choice of therapy among patients
[15,16] where many people hold the misconception that
these products are natural, and hence, safe to use with-
out adverse effects. In reality, the addition of herbal
medicines to conventional treatment regimens holds the
potential of herb-drug interactions [17]. Natural prod-
ucts are classified as biologically based therapies, includ-
ing herbs, botanicals, vitamins and minerals, and dietary
supplements. With high use but limited disclosure of
CAM use, patients may impose on themselves risks such
as making uninformed decisions regarding other treat-
ments involving drug interactions, and misdiagnosis and
mismanagement of their disease. Serious complications
may develop as a result, affecting the course of their dis-
ease. For example, Leung et al. [18] found that 34.1% of
natural products users who consumed herbs, botanicals,
vitamins and supplements orally while on warfarin ther-
apy were at risk of excessive bleeding. Some natural
products may also cause interactions with anticancer
drugs by inducting drug-metabolizing enzymes and
ATP-binding cassette drug transporters, which lower
plasma levels of the anticancer drugs and may lead to
cancer treatment failure. Some examples of natural
products that could cause adverse effects in anticancer
therapy are kava-kava, vitamin E, quercetin, ginseng,
garlic, beta-carotene and Echinacea [19]. This withhold-
ing of information between patients and conventional
healthcare professionals increases the possibility of ser-
ious herb-drug interactions occurring which may have a
negative impact on the patients’ health. However, the de-
cision of patients to withhold disclosure about their use
of natural products remains a complex issue to be ex-
plored. There is an urgent need to understand the pro-
file characteristics of patients who are likely to disclose
the use of natural products versus those who are unlikely
to do so, as well as the reasons for which patients hesitate
to disclose this information. Therefore, the purpose of this
study is to shed light on 1) the reasons some patients
choose to disclose their use of natural products to conven-
tional healthcare professionals while others choose not to,
and 2) the factors associated with these decisions.
Methods
Design
This study employed a mixed method design integrating
both quantitative and qualitative methods. This approachof qualitative-quantitative methodological triangulation
reconciles the two methods which embody incompatible
assumptions [20]. In this study, a sequential mixed-model
design was used, incorporating quantitative data obtained
from surveys with qualitative data from semi-structured
interviews to better explore the phenomena that could not
be quantified. This model design use qualitative data to
explain in more detail of quantitative findings and help to
better understand how the personal experiences of dis-
closure about the use of natural products to conventional
healthcare professionals.
Sample
A sample of patients who attended medical and surgical
clinics at the Zuoying Armed Forces General Hospital in
Taiwan between August 2007 and August 2008 were in-
vited to participate. To qualify for inclusion, patients
had to meet the following criteria: 1) over the age of 18,
2) using at least one natural products in the past
12 months and 3) sufficient ability to understand and re-
spond to all questions on the survey instrument. A total
of 521 patients were screened for CAM use and 358 pa-
tients (68.73%) reported using CAM. However, only 257
patients who reached the inclusion criteria of having
used natural products prior to the study were recruited.
The patients from the qualitative phase of the study
were selected from the overall pool of patients in the
quantitative phase. A purposive sampling strategy was
used for this phase in order to select those who were able
to discuss their decision about the disclosure of natural
products use, came from diverse demographic back-
grounds and were information rich [21]. In the qualitative
phase, we recruited a total of 39 patients, and conducted
interviews until there was data saturation—in other words,
when further sampling yielded no new information [22].
Instrument & interview guide
The survey was divided into three sections relating to
the sample characteristics, information about their use
of natural products and attitudes towards the use of
CAM. Sample characteristics collected included demo-
graphic and clinical information about the patients’ age,
gender, education level, occupation, marital status, dur-
ation of disease, frequency of clinic visits and level of
medication compliance. Information about the use of
natural products included how to mix use of natural
products and conventional treatment, knowledge of nat-
ural products, and whether patients disclosed their use of
natural products to conventional healthcare professionals.
Patients’ attitudes towards CAM use was assessed
using the scales modified from the works of Hsu et al.
[23] and Chang et al. [24] in which the scale focused on
the perceived benefits of and perceived barriers to the
use of CAM for depression and diabetes, respectively. In
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were deleted so that items suited all outpatients. A 20-
item scale enquiring on a 4-point Likert scale from
‘strongly disagree’ to ‘strongly agree’ was used to assess
the attitudes of patients towards CAM use, where a
higher score indicates a positive attitude toward CAM
and lower score hold a negative attitude towards CAM.
Cronbach’s alpha, a measure of internal consistency reli-
ability, was 0.8–0.92 in both studies. Cronbach’s alpha in
the present study showed acceptable reliability for both
the benefits (α = .87) and the barriers (α = .91) of CAM
use. The content validity of the instrument was estab-
lished by a panel of experts. Three academic healthcare
professionals and two nurses who were either experts in
CAM research, conventional health care or research
methods evaluated the instrument and minor adjust-
ments were made.
A semi-structured interview guide was developed for
the qualitative research to answer the research question
‘What is your experience with regard to discussing your
use of natural products with conventional healthcare
professionals?’ To facilitate the interview, patients were
probed to further elaborate on describing their decisions
to disclose the use of natural products or to clarify areas
of confusion. The interview guide was reviewed by a
panel of experts. Qualitative rigour was ensured in the
follow ways: (1) verbatim recording, transcribing of re-
cordings and writing of notes during the process of
interview were carried out and (2) any paraphrasing of
interview content done on the part of the researchers
was verified when the patients came down to the clinics
for during their next appointment. This happened for
two of the patients. Feedback from these patients con-
firmed that most of the findings presented their point of
view and only clarification on minor misunderstandings
of patients’ words was done because of the use of dialect
during the interview.
Ethical consideration
The study was approved by the hospital ethics commit-
tee for human subjects and followed the Declaration of
Helsinki. Patients were given an information sheet
explaining the research and the ethical considerations,
and then signed informed consent forms. All patients
were informed that a refusal or a termination of their
participation would not have any adverse consequence
on their care within the facility. Patient codes were used,
instead of their names, to ensure confidentiality.
Statistical analyses
The quantitative data were scanned for completeness and
responses were coded and entered into the computer
using IBM® SPSS® for Windows Version 17.0. Demo-
graphic characteristics and clinical data were summarisedthrough descriptive statistical procedures. Comparisons
were made between ‘disclosers’ and ‘non-disclosers’ using
inferential statistics. Stepwise multiple logistic regression
with the Hosmer–Lemeshow goodness-of-fit tests was
performed to explore the factors associated with the dis-
closure of the use of natural products. The significance
threshold for all analyses was 0.05.
Qualitative data from the interview were analysed by
using the three-step coding method: (1) open coding, (2)
axial coding and (3) selective coding [25]. In order to
strengthen the reliability of the interpretations and find-
ings, the raw data were analysed in Chinese by two sep-
arate researchers to ensure findings that are authentic,
original, and reliable. After completing the coding, the
researchers discussed their individual findings to detect
potential biases or inappropriate subjectivity and all
disagreements were discussed until a consensus was
achieved. Then, the researchers chose categories and
subcategories which best described the experience of
each patient regarding the decision of whether to dis-




A total of 257 patients were recruited in the quantitative
phase, including 190 people who chose not to disclose
the use of natural products and 67 people who chose to
disclose. The rate of non-disclosure in this study is 74%.
Sample demographic and clinical data are presented in
Table 1, delineated along patients who chose to disclose
the use of natural products or not. The mean age of the
patients was 54 years (SD = 15 years; range: 20–87), and
the mean duration of their disease was 6.5 years (SD =
6.8 years; range: 1 month to 35 years). The majority of
patients had completed at least high school (68.5%),
were married (60.3%), were retired (40.1%), visited the
clinic monthly (63.0%), and higher medication compli-
ance (75.5%). Among the 257 patients who used natural
products, only 26% (n = 67) disclosed their use to their
healthcare professionals. In the qualitative phase, 39 of
these patients were interviewed (14 men and 25 women;
mean age = 60 years; range: 38–87). Their education
levels ranged from primary school education to a mas-
ter’s degree.
Differences in attitudes toward CAM use between
disclosers and non-disclosers
The results indicated that patients who disclose the use
of natural products had higher total scores on the per-
ceived benefits of CAM use than people who chose not
to disclose (Z = −2.10, p = .036). Within the scale of the
perceived benefits of CAM use, the disclosers strongly
believed that CAM can relieve symptoms (Z = −2.86,
Table 1 Comparisons between non-disclosers and disclosers
Variables Non- Disclosers n = 190 Disclosers n = 67 t-test p
valueMean SDa Mean SD
Age 55.5 15.3 50.9 15.0 2.15 0.032
Duration of disease 1.70 1.45 1.36 1.48 1.67 0.091
Mann–Whitney U test
Benefits of CAMb use 25.5 5.8 26.7 5.3 −2.10 0.036
Barriers of CAM use 24.3 6.1 25.2 5.8 −1.05 0.295
n % n % Chi-square
Gender 0.09 0.771
male 84 44.2 31 46.3
female 106 55.8 36 53.7
Education 1.59 0.208
<high school 64 33.6 17 25.4
>high school 126 66.3 50 74.7
Occupation 0.33 0.847
working 70 36.8 27 40.3
not working 42 22.1 15 22.4
retired 78 41.1 25 37.3
Marriage 3.58 0.310
single 47 24.7 18 26.9
married or partner 111 58.4 44 65.7
divorce 5 2.6 1 1.5
wifeless or widow 27 14.2 4 6.0
Clinic visited 6.81 0.033
fortnightly 14 7.4 1 1.5
monthly 124 65.3 38 56.7
seasonally 52 27.3 28 41.8
Medication compliance 1.89 0.596
not taken 26 13.7 13 19.4
sometime taken 7 3.7 2 3.0
most time taken 10 5.3 5 7.5
always taken 147 77.4 47 70.1
How to mixed with conventional medicines 8.74 0.068
no change 51 26.8 26 38.8
separately taken 106 55.8 38 56.7
reduce medicine dose 8 4.2 0 .0
stop medicine 12 6.3 1 1.5
others 13 6.8 2 3.0
Knowledge of natural products 11.50 0.001
unknown 132 69.5 31 46.2
known 58 30.5 36 53.7
a = Standard deviation; b = Complementary and alternative medicine.
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believed that their CAM use decreases the need for con-
ventional medications (Z = −2.49, p = .013). However, no
significant difference was noted on the attitudes towards
the barriers of CAM use between disclosers and non-
disclosers (Z = −1.05, p > .295).
Predictors of disclosure in using natural products
According to the results presented in Tables 1 and 2,
significant differences between non-disclosers and dis-
closers were found in relation to age (t = 2.15, p = .032),
frequency of clinic visits (χ2 = 6.81, p = .033), the propor-
tions of patients who know the ingredients of the natural
products (χ2 = 11.50, p = .001), and the perception of
benefits (attitudes) of CAM use (Z = −2.1, p = .036). All
the variables and scale items were entered into the mul-
tiple logistic regression analysis. The findings showed
that the knowledge of natural products (OR = 2.63, CI =
1.43–4.85) was the strongest factor associated with dis-
closure, followed by the belief that CAM use can im-
prove energy (OR = 1.88, CI = 1.10-3.22), believing that
CAM use can strengthen the conventional medicine
(OR = 1.86, CI = 1.08-3.19) and the frequency of clinic
visits (OR = 1.57, CI = 1.15-2.67). Only one variable is re-
verse from others which is that CAM user believe better
to use one alone (OR = 0.35, CI = 0.19-0.64).
Qualitative data – The decision regarding the disclosure
of using natural products
The decision on whether or not to disclose the use of nat-
ural products to conventional healthcare professionals is a
very personal matter. During the semi-structured inter-
views, patients who did not disclose their natural products
use were asked about their reasons and patients who chose
to disclose their use of natural products were asked about
their feelings regarding the responses and reactions re-
ceived from their professionals. Results from the interviews
indicated that 26 patients who did not disclose the use of
natural products felt that disclosure was not necessary for
the following reasons: they felt that the use of natural prod-
ucts were safe, they had consulted others about the safety
of the natural products and they feared that they might de-
velop a negative relationship with their conventional heathTable 2 Predictors of disclosing natural products use
Factors B S.
E.
The knowledge of CAM components 1.00 .31
The improvement of energy .68 .26
The strength of my conventional medicine .59 .30
The frequency of clinic visits .37 .15
Better to use one alone −1.06 .31
1. Hosmer and Lemeshow Test (X2 = 5.61, p = .69); 2. Cox & Snell R Square = .127 & Ncare professionals. On the other hand, 13 patients who dis-
closed the use of natural products reported that the re-
sponses from conventional healthcare professionals were
not favourable. Patients’ experiences were that they felt be-
ing pushed away from the use of natural products, that the
safety of its usage was entirely their own responsibility or
that the communication was generally unclear or dismis-
sive. All the categories are listed in Table 3.
Patients who chose not to disclose felt that natural
products were safe to use. Their methods included con-
suming the natural products at a different time from
their conventional medicine, lowering the dosage of the
conventional medicine or taking natural products that
do not target the treatment of their primary medical
condition. These rationalisations helped them feel that
there were no safety issues related to the use of the nat-
ural products. One patient related, ‘I took them separ-
ately…, I think it is safe, so I did not discuss with the
conventional healthcare professional’ (P1). Several pa-
tients believed that some natural products such as nutri-
tional supplements have no side effects or interaction
with conventional medicine. When asked if they were
afraid of combining the two remedies, they replied, ‘It is
a health product (nutritional supplement) and has no
interaction with conventional medicine’ (P12).
Patients who felt that using the natural products were
safe did not feel that there is a need to discuss this with
their conventional healthcare professionals. However,
when people felt uncomfortable or sceptical about the
products, they would seek advice from their family
members or talk to acquaintances who worked in the
medical field; for example, ‘I also have a friend who is a
sales representative for pharmacies. Before I tried this
product, I asked my friend to check it and she said it
was all right’ (P33). The findings show that when pa-
tients had questions about natural products, they usually
made enquiries about it from their friends whose work
had some relation to the medical field, but they seldom
raised those concerns with their conventional healthcare
professionals.
Patients expected a negative relationship would de-
velop with the disclosure of their natural products usage





2.71 1.47 5.01 .001
1.97 1.18 3.30 .010
1.81 1.00 3.27 .050
1.44 1.07 1.95 .017
.35 .19 .64 .001
agelkerke R Square = .186.
Table 3 Findings from qualitative data
Themes Categories
Feeling safe with the use of
natural products
• Adjusting taken both medicines





• Family & relatives
• CAM practitioners
Fear of a negative relationship
development
• Anticipating a negative attitude from
conventional healthcare professional
• Affecting a trust relationship
between conventional healthcare
professional and patients
• Lack of knowledge in the field of
natural products.
Experience of responses • Discouraging them from using it
• Our own responsibility for the safety
of its usage
• Unclear or dismissive
communication
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professional, having a breakdown of trust between pa-
tient and conventional healthcare professional and the
fear of a negative attitude held towards them. In general,
a recurring point that emerged is that conventional
healthcare professionals hold negative perspectives about
their use of natural products. The negative reaction an-
ticipated during medical consultation was a strong factor
leading to the avoidance in discussion about their use of
natural products. Patient 4 revealed, ‘The biggest reason
is that I am afraid of being scolded by a conventional
healthcare professional.’ Patient 15 explained, ‘I have
never discussed, because some of the conventional
healthcare professionals will reject it (natural products)
and also scold you said ‘if you are so good at this, you
can just treat yourself.’ It depends on the degree of (the)
conventional healthcare professional’s acceptance’ (P15).
In addition, many patients also complained about the
difficulties in discussing natural products with those pro-
fessionals. They reported that conventional healthcare
professionals looked ‘unhappy’ (P30), ‘not happy’ (P2),
and ‘not too happy’ (P13).
Patients were also afraid that if they disclose their use
of natural products, the level of patient-conventional
healthcare professional trust would change. For example:
If you told a conventional healthcare professional
about this, he would say you don’t believe him, simply
don’t come back to clinic. I am terrified if he said like
this. Some of the healthcare professionals are so that
(mean)… he (conventional healthcare professional)
would say ‘this is inappropriate, you already visitconventional healthcare professional with a good
health outcome, why you need to see TCM
(traditional Chinese medicine) practitioner at the
same time.’ It let you feel you actually don’t believe in
conventional medicine (P26).
In the presence of the conventional healthcare profes-
sional as the authoritative figure, many patients experi-
enced a fear of disclosing their use of natural products
during consultations. However, in order to avoid any ad-
verse reactions occurring with the use of both natural
products and conventional medicines, patients were
more willing to disclose the issue to their CAM practi-
tioners. This can be observed in patient 37 who reported,
‘if the same situation (the disclosure of conventional medi-
cine) happened with a CAM practitioner, he would be able
to incorporate his medicine with the conventional medi-
cine.’ In addition to fear, the patients felt that conventional
healthcare professionals do not have adequate knowledge
about the natural products to respond to their concerns
and this was highlighted by patient 8:
‘Because you (conventional healthcare professionals)
don’t understand the Chinese herbal medicine
comparatively…People have their own speciality, so I
asked him [CAM practitioner].
Our findings revealed that patients’ sense of safety re-
garding the use of the natural products, consultation of
others in related fields, and fear of negative reactions
from the professionals were major considerations in the
non-disclosure of using natural products. Additionally,
insufficient knowledge regarding natural products on the
part of the conventional healthcare professionals also
contributed to this lack of disclosure.
For 13 patients who disclosed their use of natural
products, it was revealed that they experienced the feel-
ing of being pushed away from the use of natural prod-
ucts, were told that adverse effects of consumption fall
within their own responsibility, they felt they were being
discouraged from continuing its use and that communi-
cation regarding their use of natural products was not
always clear. A patient mentioned that his continued dis-
closure depended on the professional’s attitude.
So I did mention a little bit [of using natural
products] to the healthcare professional and see his
reaction. If he did not think so or no any response,
then I won’t continue to ask. So I felt medical staff ’s
attitude is very important (P19).
Some conventional healthcare professionals seem to
have taken advantage of the patients’ fears of the profes-
sionals’ own authority as healthcare practitioners in
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sense of apathy and unwillingness to have open discus-
sions about patients’ use of natural products. These pa-
tients quoted conventional healthcare professionals’
responses as follows: ‘you better watch out for it’ (P24),
‘better don’t take it’ (P35), ‘it is wasted money’ (P6), ‘you
better don’t take any natural product’ (P17), and ‘the
best way is to take the prescription medication’ (P28).
The second response from conventional healthcare
professionals that the conventional healthcare profes-
sionals emphasised the lack of scientific evidence to sup-
port the effectiveness of natural products and hence any
adverse effects was entirely their own responsibility. As
patient 39 elaborated, her conventional healthcare pro-
fessional commented that ‘you just take a little bit, it’s all
right’ when she disclosed her use of natural products.
Patient 3 reported that his conventional healthcare pro-
fessional said ‘it’s all right only if you don’t feel any dis-
comfort.’ The response of ‘you may do it’, suggests that
the conventional healthcare professionals were support-
ive of the patient’s choice regarding the use of natural
products but frequently with the condition that the nat-
ural products does not have any adverse effect or that
they do not take too much of it. Therefore, if any prob-
lem were to arise, it would entirely be the patient’s own
responsibility.
When my liver function levels [serum glutamic-
oxaloacetic transaminase (GOT) and glutamic-pyruvic
transaminase (GPT)] were down a lot… I proposed
whether or not these things [natural products] had
made the improvement to the healthcare professional
and he didn’t think so. He indicated that these [ther-
apies] have not been proven through clinical trials. He
said ‘you may do it!’ But based on his expertise, it is
not his field. (P14).
However, the patient felt that it was best to avoid fur-
ther discussion of about the use of natural products be-
cause of the apparent noncommittal reply from the
conventional healthcare professional that led to the con-
clusion that the healthcare professional did not wish to
discuss the use of natural products (‘unclear communi-
cation’). From the patients’ experience and perception,
there is a strong indication that tensions exist in the
relationship between the patient and the conventional
healthcare professional regarding this issue.
Discussion
This study used a mixed method design to illustrate the
communication of natural product usage to conventional
healthcare professionals among outpatients. Our find-
ings identified that 74% of natural product users did not
disclose their usage to their healthcare professionals andthis is slightly higher than the rates found in previous
studies [9,26,27]. Research on the factors predicting the
disclosure of using natural products to conventional
healthcare professionals is limited and, consequently,
there is a lack of knowledge on factors influencing the
decision to disclose and not to disclose. This study iden-
tified factors previously unexplored, which have consid-
erably refined the understanding of the reasons for the
disclosure of natural product usage in conventional
healthcare settings. Our findings indicated that dis-
closers were younger, visited health clinics roughly every
3 months, were aware of the ingredients of the natural
products they were consuming and felt positive about
the benefits of CAM. It is difficult to compare the find-
ings of this study with previous studies because the fac-
tors surveyed in this study were not well documented in
the literature. Among the four recent studies examining
the factors associated with the disclosure of CAM use
[26-29], only the factor of age was a consistent finding
reflected within the current study where middle-aged
people were more likely to disclose their use of natural
products. It is likely that the inconsistencies in the find-
ings in relation to the aforementioned variables are due
to differences ranging from the ethnicity and culture of
the samples, research design, and the range of factors
looked into.
The quantitative analysis indicates variables such as
knowledge of natural products and attitudes towards the
benefits of CAM. People who knew what they were tak-
ing and believed in the effectiveness of natural products
were curious as to whether the improvement in their
health was the result of such usage. Another surprising
finding is the frequency of clinical visits, in which pa-
tients who visited the clinic every three months (i.e., sea-
sonally) were more likely to discuss their use of natural
products with conventional healthcare professionals than
those who visited monthly or fortnightly, mainly because
those who attended clinics every three months usually
have a long-term relationship with their healthcare profes-
sional, due to the chronic nature of their disease, and thus
visit clinics regularly for the treatment. A possible explan-
ation is found in other studies in which people who visited
their personal healthcare professional [29] and received
continuous care were more likely to disclose their use of
natural products during the consultation [30,31].
The major barrier to the disclosure of using natural
products to conventional healthcare professionals, as re-
ported in the qualitative findings, was that it never
crossed the patients’ minds because they felt it was safe
to use these products as they were natural. However, it
was also noted that many were afraid to discuss their
use of the natural products as they were concerned that
that would have them leave a negative impression on
their conventional healthcare professionals. Additionally,
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natural products with their healthcare professionals due to
the perceived negative attitudes of the conventional health-
care professional towards the use of natural products, des-
pite fears of adverse effects or complications resulting from
combining the two forms of treatments. This is in line with
the findings from the review by Robinson and McGrail [32]
that patients avoid such discussions as they might garner
distrust or dissatisfaction from the conventional healthcare
professionals, which in turn may put their relationship at
risk. One of the greatest concerns about the use of natural
products is the potential for interaction with on-going con-
ventional treatment because most patients were simultan-
eously engaged in conventional care and were often on
numerous medications. The addition of any undisclosed
nutritional supplements, herbs, or remedies may increase
the risk of possible adverse reaction or interactions. Al-
though patients reported having clarified their concerns
regarding herb-drug interaction from others with some
medical background, it is important to note that these
people may not be qualified to give advice on specific dis-
ease management. One interesting phenomenon revealed
within the in-depth interviews is that patients often detailed
their conventional medication treatment to their CAM
practitioners but not the other way round.
Limitations of the study
This study has several limitations. The first limitation is
that the design involved retrospective data collection,
making the data subject to recall bias. A second limita-
tion is associated with the issue of sampling bias. Quan-
titative data was collected to estimate the prevalence of
CAM use where the non-users of CAM were subse-
quently excluded and this may result in potential bias of
selection. Nevertheless, the ratio of patients who dis-
closed their use of natural products is consistent with
other studies; therefore, the risk of selection bias is of
little concern.
Implementations
Having an open communication between patients and
healthcare professionals with regard to the use of natural
products is the key to ensuring safe implementation and
integration of both medicines. Furthermore, the issues
of regulation, quality, safety, and efficacy are exceedingly
important to patient care. However, even though these
questions are crucial in the communication process, be-
ginning the consultation session with these questions
might imply a pre-judgemental attitude towards the pa-
tients’ decision to use natural products. It is an oppor-
tunity for the conventional healthcare professionals to
make a difference by approaching the interview with an
open mind so as to encourage patients to disclose their
use of natural products. Hence, it is necessary toestablish new strategies and train the healthcare profes-
sionals in creating a supportive and collaborative atmos-
phere during consultations. As such, training on how to
discuss the use of natural products would reduce the like-
lihood of patients taking potentially harmful natural prod-
ucts, ensure that the use of these products would be
careful monitored and improve healthcare education for
the patients.
In addition, serious adverse interactions could occur if
the health professionals are unable to give appropriate ad-
vice because they do not have reliable knowledge of the
natural products and are unfamiliar with the scientific lit-
erature on natural products. In particular, previous studies
have shown that many conventional healthcare pro-
fessionals feel uncomfortable discussing the effectiveness
of natural products with their patients due to a lack of
knowledge. In fact, the lack of sufficient knowledge and
evidence-based research on CAM is a major barrier to-
wards the conventional healthcare professionals’ ability to
handle enquiries from patients about the use of natural
products and appropriately refer them to reputable CAM
practitioners [33,34]. There is an urgent need for studies
with rigorous research methodology to establish the effi-
cacy of the natural products. Without a thorough under-
standing of the pharmacodynamics of these products, it is
difficult to integrate its use in congruence with conven-
tional medicine or conduct informative education pro-
grams in the conventional medical setting. Therefore,
properly designed studies to determine the effectiveness of
natural products in both laboratory and clinical situations
are required.
In addition, the lack of discussion with patients on the
use of natural products makes it difficult for conven-
tional healthcare professionals to recognize and report
the occurrence of adverse effects and, thereby, establish-
ing drug-herb interactions. Conversely, the synergistic
effect of natural products and conventional medicines
would have been missed as well, resulting in overlooked
opportunities to validate such beneficial information.
Therefore, the development of a standard guideline for a
routine assessment of the use of natural products, a
competency assessment for consultations, and an indi-
vidualized plan for integrating natural products and con-
ventional treatments that promotes safe practice is
essential for all medical healthcare systems.
Conclusions
This study provides preliminary insights into the predic-
tors of patient’s disclosure of their use of natural prod-
ucts. It is an important issue as the use of natural
products is an emerging trend that will have increasing
impact on the delivery of healthcare with its popularity
among patients. A lack of knowledge about natural
products, self-administration of both medicines, and
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care professionals may endanger patients. Unsupervised
usage and the possibility of serious natural products-
drug interaction may compromise the management of
the disease and, hence, lead to an acerbation in condi-
tion as well as an increase in the utilization of the
healthcare system in these patients. Since providing pa-
tients with responsible healthcare intervention from a
holistic perspective is the essence of effective health care,
it is important for healthcare professionals to understand
the characteristics of patients who are more likely, or
less likely, to disclose their use of natural products. The
healthcare professionals need to take a leading role by
recording the use of natural products in order to under-
stand the effects of natural products on the patients.
This would help to assess potential benefits or harm of
the natural products and aid in the tracking of any side
effects from its use. In addition, it is important to look
into modification of the medical model of care into a
more holistic model that integrates the use of natural
products into the disease management programs. This
will have the potential to ensure patient safety, reduce
unwanted side effects, improve treatment outcomes,
lower costs, and improve the professional relationship
between patient-conventional healthcare professional
relationships.
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